Somatostatin Replacement: A New Strategy for Treating Diabetic Retinopathy

E-ISSN： 1875-533x|20|26|3251-3257

ISSN： 0929-8673

Source： Current Medicinal Chemistry, Vol.20, Iss.26, 2013-09, pp. : 3251-3257

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

The Role of Growth Hormone, Insulin-Like Growth Factor and Somatostatin in Diabetic Retinopathy

Current Medicinal Chemistry, Vol. 13, Iss. 27, 2006-11 ,pp. : 3307-3317

Bentham Science Publishers

Access to resources Recommend Favorite

Potential new strategies to prevent the development of diabetic retinopathy

By Mohr Susanne

Expert Opinion on Investigational Drugs, Vol. 13, Iss. 3, 2004-03 ,pp. : 189-198

Informa Healthcare

Access to resources Recommend Favorite

Candesartan: a new DIRECTion for diabetic retinopathy?

Inpharma, Vol. 1, Iss. 1662, 2008-01 ,pp. : 19-19

Adis International

Access to resources Recommend Favorite

Emerging therapeutics for diabetic retinopathy: potential therapies for the new millennium

By Jacot J.L. Sredy J.

Expert Opinion on Therapeutic Targets, Vol. 3, Iss. 2, 1999-06 ,pp. : 307-335

Informa Healthcare

Access to resources Recommend Favorite

Editorial (Hot Topics: New Insights in the Pathogenesis and Treatment of Diabetic Retinopathy)

Current Medicinal Chemistry, Vol. 20, Iss. 26, 2013-09 ,pp. : 3187-3188

Bentham Science Publishers

Access to resources Recommend Favorite